
PARP Inhibitor and Chemotherapy Combination Improves Progression-Free Survival
(October 7, 2019) Published recently in the New England Journal of Medicine, a group of investigators led by OCRA Scientific Advisory Committee member Dr. Robert Coleman found an innovative combination … Continued